FDA Acts To Stem Shortages Of Cancer Drugs Doxil And Methotrexate
Category: WELLNESS
Doxil, a cancer drug from Johnson & Johnson, has been in persistent short supply since manufacturing problems surfaced at
By Reuters, Reuters, 2012-02-21